Stock listing
VOR Stock Price, News, Filings & Events — Vor Biopharma Inc.
Selected listing: VOR · BOATS · USD · US
This page tracks Vor Biopharma Inc.'s VOR:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VOR:BOATS. VOR:BOATS is the stock-level entry point for investors researching Vor Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vor Biopharma Inc. is a public company traded under the ticker VOR in the American market. The company has a market capitalization of approximately $1.04 billion. Vor Biopharma focuses on developing innovative therapies to treat cancer through its proprietary technology.

- Ticker
- VOR:BOATS
- Asset type
- Stock
- Market cap
- $1.34B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Vor Biopharma Inc. VOR:BOATS stock context
This page tracks Vor Biopharma Inc.'s VOR:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VOR:BOATS. VOR:BOATS is the stock-level entry point for investors researching Vor Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vor Biopharma Inc. is a public company traded under the ticker VOR in the American market. The company has a market capitalization of approximately $1.04 billion. Vor Biopharma focuses on developing innovative therapies to treat cancer through its proprietary technology.
Latest news from Vor Biopharma Inc.
Vor Bio To Participate in Upcoming September Conferences
September 1, 2026
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
Vor Bio Appoints David Zaccardelli to Board of Directors
July 7, 2026
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
June 8, 2026
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
June 8, 2026
Research Vor Biopharma Inc.
Vor Biopharma Inc. investor report
Review AI stock analysis and investor report context for VOR:BOATS.
Vor Biopharma Inc. company profile
View the public company page for Vor Biopharma Inc. on 6ix.
Vor Biopharma Inc. news
Read company news and market updates connected to Vor Biopharma Inc..
Vor Biopharma Inc. investor events
Find investor webinars, events, and replay context for Vor Biopharma Inc..